Insider Buying: Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Buys $119,914.74 in Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon acquired 168,894 shares of the company’s stock in a transaction that occurred on Monday, September 28th. The shares were bought at an average price of $0.71 per share, with a total value of $119,914.74. Following the transaction, the chief executive officer owned 3,646,133 shares in the company, valued at $2,588,754.43. This represents a 4.86% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Inspira Technologies OXY B.H.N. Price Performance

NASDAQ:QTEX traded down $0.01 on Tuesday, reaching $0.67. The stock had a trading volume of 4,356,021 shares, compared to its average volume of 10,831,636. Inspira Technologies OXY B.H.N. Ltd has a 12-month low of $0.28 and a 12-month high of $3.85. The stock’s fifty day simple moving average is $0.89. The company has a current ratio of 2.00, a quick ratio of 1.62 and a debt-to-equity ratio of 0.12.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last issued its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. announced that its Board of Directors has initiated a share buyback program on Monday, June 22nd that permits the company to buyback 2,000,000,000,000 outstanding shares. This buyback authorization permits the company to reacquire up to 5.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on QTEX shares. Wall Street Zen lowered Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings raised Inspira Technologies OXY B.H.N. from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is an Israeli medical technology company focused on developing advanced respiratory-support systems for patients experiencing acute respiratory failure. The company’s technology is intended to support blood oxygenation and carbon-dioxide removal while potentially reducing reliance on invasive mechanical ventilation.

Its principal product platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.